Advanced search×

Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2^V^6^1^7^F mutation

Leuk Res 35(9):3 (2011) PMID 21764129

Copyright © 2011 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.leukres.2011.06.008
Version: za2963e q8za6 q8zbf q8zcf q8zdc q8zec q8zfa q8zg1

Similar articles you may find interesting…

  1. Factors associated with reduced efficacy of sitagliptin therapy: analysis of 93 patients with type 2 diabetes treated for 1.5 years or longe...

    J Clin Med Res 5(3):217-21 (2013) PMID 23671547

    Several studies have shown the effectiveness of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for type 2 diabetes, with a hypoglycemic effect being demonstrated both when it is administered alone or in combination with other oral antidiabetic agents. However, there are few reports...
  2. Treating Fragile X syndrome with the diuretic bumetanide: a case report.

    Acta Paediatr 102(6):e288-90 (2013) PMID 23647528

    We report that daily administration of the diuretic NKCC1 chloride co-transporter, bumetanide, reduces the severity of autism in a 10-year-old Fragile X boy using CARS, ADOS, ABC, RDEG and RRB before and after treatment. In keeping with extensive clinical use of this diuretic, the only side effect w...
  3. Renal impairment and coronary collaterals in patients with acute coronary syndrome.

    Herz (2013) PMID 23649321

    The mean eGFR value was 89.9 ± 24.3 U/l for patients with no development of collaterals and 82.7 ± 20.5 for patients who had CCV. The mean age was 59 ± 11 years and 349 patients (75.7 %) were male. Rentrop classifications 1-2-3 (presence of CCV) were determined in 222 (48.1 %)...